A Multicenter Clinical Evaluation of Safety and Efficacy of Lumason as a Contrast Agent in Pediatric Echocardiography

Trial Profile

A Multicenter Clinical Evaluation of Safety and Efficacy of Lumason as a Contrast Agent in Pediatric Echocardiography

Recruiting
Phase of Trial: Phase III

Latest Information Update: 01 Mar 2017

At a glance

  • Drugs Sulfur hexafluoride (Primary)
  • Indications Congenital heart defects; Heart disorders
  • Focus Diagnostic use
  • Sponsors Bracco Diagnostics
  • Most Recent Events

    • 20 Jan 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 18 May 2015 Planned initiation date changed from 1 Mar 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov record.
    • 07 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top